Preclinical Evaluation of MoAbs Mc5 and BrEl

  • Roberto L. Ceriani
  • Hector Battifora
  • Edward W. Blank
  • Jerry A. Peterson
  • Cindy Zoellner

Abstract

Breast epithelial cells possess antigenic glycoprotein components which are, if not unique, characteristic to this tissue (1). Some of these antigens are shared with other epithelial tissues of the body. In addition, neoplastic breast epithelial cells possess certain epitopes on their glycoproteins that could be oncofetal in nature and are considered tumor specific by others. They are epitopes that are made more available as a result of a lack of oligosaccharide maturation. These previously unavailable epitopes are made available, by non-lethal glycosyltransferase deletions introduced by neoplasia. As a result of these deletions inner-core saccharide sequences previously blocked by terminal monosaccharides are exposed as well as epitopes of the polypeptide previously shielded by completely synthesized oligosaccharides.

Keywords

Breast Cancer Maximum Tolerable Dose Breast Epithelial Cell Human Breast Tumor Nude Mouse Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. L. Ceriani, K. E. Thompson, J. A. Peterson and S. Abraham, Surface differentiation antigens of human epithelial cells carried on the human milk fat globule. Proc. Natl. Acad. Sci. USA 74:582–586 (1977).PubMedCrossRefGoogle Scholar
  2. 2.
    R. L. Ceriani and J. A. Peterson, Characterization of differentiation antigens of the mouse mammary epithelial cell (MME antigens) carried on the mouse milk fat globule. Cell Differentiation 7:355–366 (1978).PubMedCrossRefGoogle Scholar
  3. 3.
    A. Thor, N. Ohuchi, C. A. Szpak, W. W. Johnston and J. Schlom, Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 46:3118–3124 (1986).PubMedGoogle Scholar
  4. 4.
    J. Taylor-Papadimitriou, J. A. Peterson, J. Arklie, J. Burchell, R. L. Ceriani and W. F. Bodmer, Monoclonal antibodies to epithelial-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int. J. Cancer 28:17–28 (1981).PubMedCrossRefGoogle Scholar
  5. 5.
    R. L. Ceriani, J. A. Peterson, J. Y. Lee, F. R. Moncada and E. W. Blank, Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somat. Cell Genet. 9:415–427 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    C. S. Foster, P. A. Edwards, E. A. Dinsdale and A. M. Neville, Monoclonal antibodies to the human mammary and extra mammary tissues. Virchows Arch (Pathol. Anat.) 394:279–293 (1982).CrossRefGoogle Scholar
  7. 7.
    D. Colcher, P. H. Hand, M. Nuti and J. Schlom, A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc. Natl. Acad. Sci. USA 78:3199–3203 (1981).PubMedCrossRefGoogle Scholar
  8. 8.
    L. D. Papsidero, G. A. Croghan, M. J. O’Connell, L. A. Valenzuela, T. Nemoto and T. M. Chu, Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma. Cancer Res. 43:1741–1747 (1983).PubMedGoogle Scholar
  9. 9.
    R. L. Ceriani, D. L. Hill, L. Osvaldo, C. Kandell and E. W. Blank, Immunohistochemical studies in breast cancer using monoclonal antibodies against breast epithelial cell components and with lectins, in: “Immunohistochemistry in Tumor Diagnosis,” J. Russo, ed., Martinus Nijhoff Publishing, Boston, p. 233–263 (1985).Google Scholar
  10. 10.
    R. L. Ceriani, M. Sasaki, H. Sussman, W. M. Wara and E. W. Blank, Circulating human mammary epithelial antigens in breast cancer. Proc. Natl. Acad. Sci. USA 79:5420–5424 (1982).PubMedCrossRefGoogle Scholar
  11. 11.
    J. Hilkens, V. Kroezen, J. M. G. Bonfrer, M. De Jong-Bakker and P. F. Bruning, MAM-6 antigen, a new serum marker for breast cancer monitoring. Cancer Res. 46:2582–2587 (1986).PubMedGoogle Scholar
  12. 12.
    D. F. Hayes, H. Sekine, T. Ohno, M. Abe, K. Keefe and D. W. Kufe, Use of a murine monoc l onal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J. Clin. Invest. 75:1671–1678 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    T. Wilbanks, J. A. Peterson, S. Miller, L. Kaufman, D. Ortendahl and R. L. Ceriani, Localization of mammàry tumors in vivo with 131I-labeled Fab fragments of antibodies against mouse mammary epithelial (MME) antigens. Cancer 48:1768–1775 (1981).PubMedCrossRefGoogle Scholar
  14. 14.
    A. A. Epenetos, K. E. Britton, S. Mathers, J. Shepherd, M. Granowska, J. Taylor-Papadimitriou, C. C. Nimmon, H. Darbin, L. R. Hawkins, J. S. Malpas and W. F. Bodmer, Targeting of iodine-123-labelled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumors. Lancet ii:999–1003 (1982).CrossRefGoogle Scholar
  15. 15.
    R. L. Ceriani, J. A. Peterson and E. W. Blank, Breast cancer diagnosis with human mammary epithelial antigens and the prospective use of antibodies against them in therapy, in: “Mechanism of Cancer Metastases,” V. K. Hohn, W. E. Powers and B. F. Sloanne, eds., Martinus Nijhoff Publishing, Boston, p. 235–258 (1986).CrossRefGoogle Scholar
  16. 16.
    D. Hofheinz, D. Dienhart, G. Miller, S. Healy, P. Furmanski, S. Sedlacek, C. Longley, P. Bunn, K. Kortright, Monoclonal antibody, KC4G3, recognizes a novel widely expressed antigen on human epithelial cancers. 78th Annual Meeting of the AACR. Proc. AACR, 28:391, #1552 (1987).Google Scholar
  17. 17.
    B. Gould, M. Borowitz, E. Groves and A. Frankel, A phase I study of the anti-breast cancer immunotoxin 260F9 MAB-rRa given by continuous infusion, in: “Immunological Approaches to Diagnosis and Therapy of Breast Cancer II,” R. L. Ceriani, ed., Plenum Press, New York, in press (1989).Google Scholar
  18. 18.
    H. P. Kalofonos and A. A. Epenetos, Antibody guided diagnosis and therapy of patients with breast cancer, in: “Immunological Approaches to the Diagnosis and Therapy of Breast Cancer,” R. L. Ceriani, ed., Plenum Press, New York, p. 245–257 (1987).CrossRefGoogle Scholar
  19. 19.
    P. M. Capone, L. D. Papsidero, G. A. Croghan and T. M. Chu, Experimental tumoricidal effects of monoclonal antibody against solid tumors. Proc. Natl. Acad. Sci. USA 80:7328–7332 (1983).PubMedCrossRefGoogle Scholar
  20. 20.
    P. M. Capone, L. D. Papsidero and T. M. Chu, Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors. J. Natl. Cancer Inst. 72:673–677 (1984).PubMedGoogle Scholar
  21. 21.
    R. L. Ceriani and E. W. Blank, An experimental model for the immunological treatment of breast cancer, in: “Monoclonal Antibodies and Breast Cancer,” R. L. Ceriani, ed., Martinus Nijhoff, Boston, p. 248–268 (1985).CrossRefGoogle Scholar
  22. 22.
    R. L. Ceriani, E. W. Blank and J. A. Peterson, Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components. Cancer Res. 47:532–540 (1987).PubMedGoogle Scholar
  23. 23.
    R. L. Ceriani and E. W. Blank, Experimental therapy of human tumors with I labeled monoclonal antibodies prepared against the human milk fat globule. Cancer Res. 48:4664–4672 (1988).PubMedGoogle Scholar
  24. 24.
    H. Battifora, The multitumor (sausage) tissue block: Novel method for immunohistochemical antibody testing. Lab Invest 55:244 (1986).PubMedGoogle Scholar
  25. 25.
    J. A. Peterson, J. S. Bartholomew, M. Stampfer and R. L. Ceriani, Analysis of expression of human mammary epithelial antigens in normal and malignant breast cells at the single cell level by flow cytofluorimetry. Exp. Cell Biol. 49:1–14 (1981).PubMedGoogle Scholar
  26. 26.
    L. D. Papsidero, G. A. Croghan, P. M. Capone and E. A. Johnson, Ductal carcinoma antigen: characteristics, tissue distribution and capacity to represent a target for monoclonal antibody therapy, in: “Monoclonal Antibodies and Breast Cancer,” R. L. Ceriani, ed., Martinus Nijhoff Publishing, Boston, p. 293–302 (1985).CrossRefGoogle Scholar
  27. 27.
    P. H. Hand, M. Nuti, D. Colcher and J. Schlom, Definition of antigenic heterogeneity and modulation among mammary carcinoma-cell populations using monoclonal antibodies to tumor-associated antigens. Cancer Res. 43:728–735 (1983).PubMedGoogle Scholar
  28. 28.
    R. L. Ceriani, E. H. Rosenbaum, M. Chandler, T. T. Trujillo, B. Myers and M. Sakada, Role of circulating human mammary epithelial antigens (HME-Ags) as serum markers for breast cancer, in: “Tumor markers and their significance in the management of breast cancer,” Ip, C., ed., A. R. Liss, p. 3–19 (1986).Google Scholar
  29. 29.
    R. L. Ceriani, M. Sasaki, D. Orthendahl and L. Kaufman, Localization of human breast tumors grafted in nude mice with a monoclonal antibody directed against a defined cell surface antigen of human mammary epithelial cells. Breast Cancer Res. Treat. 12:177–189 (1988).PubMedCrossRefGoogle Scholar
  30. 30.
    K. Inoue, S. Fujimoto and M. Ogawa, Antitumor efficacy of seventeen anticancer drugs in human breast cancer xenograft (MX-1) transplanted in nude mice. Cancer Chemother. Pharmacol. 10:182–186 (1983).PubMedCrossRefGoogle Scholar
  31. 31.
    A. A. Epenetos, D. Snook, H. Durbin, P. M. Johnson and J. Taylor-Papadimitriou, Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res. 46:3183–3191 (1986).PubMedGoogle Scholar
  32. 32.
    M. H. Griffith, E. D. Yorke, B. W. Wessels, G. L. DeNardo and W. P. Neacy, Direct dose confirmation of quantitative autoradiography with micro-TLD measurement for radioimmunotherapy. J. Nucl. Med. 29:1795–1809 (1988).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Roberto L. Ceriani
    • 1
  • Hector Battifora
    • 2
  • Edward W. Blank
    • 1
  • Jerry A. Peterson
    • 1
  • Cindy Zoellner
    • 1
  1. 1.John Muir Cancer & Aging Research InstituteWalnut CreekUSA
  2. 2.City of Hope National Medical CenterDuarteUSA

Personalised recommendations